Guggenheim lowers Regeneron price target, says selloff ‘overdone’
Guggenheim lowered the firm’s price target on Regeneron (REGN) to $950 from $1,200 and keeps a Buy rating on the shares. The firm, which is ...
David Margulies Joins Guggenheim Securities’ Electronic Trading Business
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Margulies has joined the firm’s Equities Sales & Trading group as a ...
O’Reilly Automotive (NASDAQ:ORLY) Price Target Raised to $1,475.00 at Guggenheim
O’Reilly Automotive (NASDAQ:ORLY – Free Report) had its target price increased by Guggenheim from $1,400.00 to $1,475.00 in a report released on Friday morning,Benzinga reports. Guggenheim currently ...
allotsego4d
Yakyu | Baseball Exhibit Will Celebrate Shared Culture of Baseball in Japan, U.S.
The Transpacific Exchange of the Game” will explore the longstanding exchange of teams and players in the more than 150 years ...
BroadwayWorld5d
Works & Process At The Guggenheim To Develop New Work On Vermont's Potash Hill
Works & Process at the Guggenheim, alongside a list of renowned artists, is developing new works on Vermont's Potash Hill.
The Chronicle of Philanthropy6d
L.A. Dodgers Foundation, Walter Family Foundation Commit $100 Million for Wildfire Recovery
Plus, the Jewish Federation of Cleveland received $90 million to support five Jewish day schools in the city, and $70 million ...
Guggenheim Raises AbbVie (NYSE:ABBV) Price Target to $214.00
AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by stock analysts at Guggenheim from $212.00 to $214.00 in a ...